These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24042507)

  • 1. Reversibility of the pulmonary function based on the partial flow-volume curve predicts the efficacy of bronchodilator therapy for treating chronic cough.
    Nakade Y; Fujimura M; Ohkura N; Nakata M; Nanbu Y; Oe H; Horita H; Sakai Y; Wada T
    Intern Med; 2013; 52(18):2017-23. PubMed ID: 24042507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened cough response to bronchoconstriction in cough variant asthma.
    Ohkura N; Fujimura M; Nakade Y; Okazaki A; Katayama N
    Respirology; 2012 Aug; 17(6):964-8. PubMed ID: 22672909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma.
    Bao W; Chen Q; Lin Y; Liu H; Zhao G; Chen Z; Zhou X
    Respirology; 2013 Nov; 18 Suppl 3():53-61. PubMed ID: 24188204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methacholine-induced cough as an indicator of bronchodilator-responsive cough.
    Ohkura N; Fujimura M; Hara J; Nakade Y; Abo M; Sone T; Kimura H; Kasahara K
    Pulm Pharmacol Ther; 2020 Oct; 64():101962. PubMed ID: 33039668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of response to bronchodilator in patients with cough variant asthma- A randomized, single-blinded, placebo-controlled study.
    Yi F; Han L; Liu B; Zhang X; Xue Y; Luo W; Chen Q; Lai K
    Pulm Pharmacol Ther; 2020 Apr; 61():101903. PubMed ID: 32092472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of forced expiratory volume in 1 second (FEV1) by albuterol.
    Pisarik P
    Fam Med; 2006; 38(7):463-4. PubMed ID: 16823665
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness.
    Fujimura M; Sakamoto S; Matsuda T
    Intern Med; 1992 Apr; 31(4):447-52. PubMed ID: 1352997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator effect of deep inspiration and bronchoconstriction-triggered cough.
    Ohkura N; Fujimura M; Tokuda A; Hara J; Hori A; Nishitsuji M; Abo M; Katayama N
    Cough; 2009 Nov; 5():9. PubMed ID: 19930579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes of pulmonary function and bronchial responsiveness in cough-variant asthma treated with bronchodilators alone.
    Nobata K; Fujimura M; Tsuji H; Ishiura Y; Myou S; Nakao S; Takazakura E
    Allergy Asthma Proc; 2006; 27(6):479-85. PubMed ID: 17176782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma.
    Tagaya E; Kondo M; Kirishi S; Kawagoe M; Kubota N; Tamaoki J
    J Asthma; 2015 Jun; 52(5):512-8. PubMed ID: 25329681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma.
    Fujimura M; Ohkura N; Abo M; Furusho S; Waseda Y; Ichikawa Y; Hara J
    Respirology; 2008 May; 13(3):359-64. PubMed ID: 18399857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study.
    Azevedo KS; Luiz RR; Rocco PR; Conde MB
    BMC Pulm Med; 2012 Sep; 12():49. PubMed ID: 22950529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from structure-function studies in asthma: myths and truths about what we teach.
    Irvin CG
    J Appl Physiol (1985); 2006 Jul; 101(1):7-9. PubMed ID: 16782831
    [No Abstract]   [Full Text] [Related]  

  • 16. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
    Molimard M; Bourcereau J; Le Gros V; Bourdeix I
    Respir Med; 2005 Jun; 99(6):695-702. PubMed ID: 15878485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cough flow-volume relationships in normal and asthmatic children.
    Beardsmore CS; Park A; Wimpress SP; Thomson AH; Simpson H
    Pediatr Pulmonol; 1989; 6(4):223-31. PubMed ID: 2748217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
    Irwin RS; French CT; Smyrnios NA; Curley FJ
    Arch Intern Med; 1997 Sep; 157(17):1981-7. PubMed ID: 9308510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
    Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
    Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cough as the sole presenting manifestation of bronchial asthma.
    Corrao WM; Braman SS; Irwin RS
    N Engl J Med; 1979 Mar; 300(12):633-7. PubMed ID: 763286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.